(Q67276057)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2107173%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

review article

1 reference

title

von Willebrand disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2107173%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

author name string

Miller JL

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2107173%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

publication date

1 February 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2107173%20AND%20SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

11 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2107173%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2107173%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2107173%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

107-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2107173%20AND%20SRC:MED&resulttype=core&format=json

von Willebrand's disease and hemorrhagic telangiectasia: association of two complex disorders of hemostasis resulting in life-threatening hemorrhage

11 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Nucleotide sequence of pre-pro-von Willebrand factor cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophilization: New stable platelet preparations for von Willebrand factor assays

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

A hemorrhagic syndrome in Waldenström's macroglobulinemia secondary to immunoadsorption of factor VIII. Recovery after splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

A comparative study of variables affecting the bleeding time using two disposable devices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Telangiectasia and von Willebrand's Disease in Two Families

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Role of von Willebrand factor in the vessel wall

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Adenosine diphosphate induces binding of von Willebrand factor to human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Pathogenesis of antibody-induced acquired von Willebrand Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Plasma and platelet von Willebrand factor defects in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Von Willebrand factor multimer patterns in von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Synthesis of von Willebrand factor by cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

The interaction of bovine factor VIII with human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Hemostatic evaluation in bleeding disorders from native blood. Clinical experience with the hemostatometer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Multimeric analysis of von Willebrand factor in megakaryocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

IIB von Willebrand's disease: pathogenetic and therapeutic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

von Willebrand protein facilitates platelet incorporation in polymerizing fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Investigation of a large kindred with type IIB von Willebrand's disease, dominant inheritance and age-dependent thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

A monoclonal antibody based immunoradiometric assay for von Willebrand factor: survey of a large patient group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Acquired von Willebrand disease associated with an inhibitor to factor VIII antigen and gastrointestinal telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Synthesis of Factor VIII Antigen by Cultured Guinea Pig Megakaryocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Essential thrombocythemia with acquired von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Platelets have more than one binding site for von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Cloning and characterization of two cDNAs coding for human von Willebrand factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Gene deletions correlate with the development of alloantibodies in von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Inducible secretion of large, biologically potent von Willebrand factor multimers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Studies on the pathophysiology and treatment of von Willebrand's disease. IV. Mechanism of increased ristocetin-induced platelet aggregation in von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Platelet aggregation induced by DDAVP in platelet-type von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Botrocetin- and polybrene-induced platelet aggregation in platelet-type von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

DDAVP in acquired von Willebrand syndrome associated with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Multimeric composition of plasma von Willebrand factor in chronic myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Amino acid sequence of human von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Successful treatment of an acquired von Willebrand factor antibody by extracorporeal immunoadsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Factor VIII and human platelet aggregation. III. Further studies on aggregation of humna platelets by neuraminidase-treated human factor VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

The Factor VIII Abnormality in Severe von Willebrand's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

von Willebrand disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930508-2

7 January 2021

10.1016/S0889-8588(18)30508-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2107173%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference